Stock screener

PALI

Conviction 47HealthcareScan · Thu, Jun 25, 2026
PALI$1.80-6.51%
ResistanceSupportVol 14
63 bars
Vol MA14 2.87M
Mar 26Apr 14May 1May 19Jun 8Jun 25
PALISADE BIO, INC.BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.palisadebio.com
Price1.80
Change-6.51%
Gap-0.52%
Rel volume2.40×
Avg volume2.79M
Avg $ vol5.11M
SMA 201.85
SMA 501.97
SMA 2001.80
Price vs 50-8.87%
Price vs 200-0.39%
MA stackmixed
50/200 cross
Supertrenddown · 2.09
RSI (14)46
MACD hist0.02
MACD crossbull · 4d
Stoch %K / %D40 / 59
ADX (14)14
+DI / −DI22 / 20
RSI divergence
MACD divergence
ATR %+7.80%
ADR %7.41%
52w high2.80
52w low0.5390
From 52w high-35.89%
Above 52w low+233.02%
New 52w highNo
SqueezeOff
Bollinger width28.29%
%B0.40
Donchian pos30.39%
Donchian high2.15
Donchian low1.64
AVWAP (52w high)1.97
vs AVWAP high-9.01%
AVWAP (52w low)1.82
vs AVWAP low-1.25%
OBV trendDown
Chaikin MF (20)-0.33
Today vs 20d2.40×
Avg vol (14d)2.87M
Avg vol (20d)2.79M
Avg $ vol (20d)5.11M
Market cap311.58M
RS 3m (vs SPY)-16.26%
RS 6m (vs SPY)-2.82%
RS line new highNo
Trend template4/8
Technical rank26.8
1 week+1.99%
1 month-9.80%
3 months-10.25%
6 months-13.70%
1 year+142.80%
YTD-28.20%
P/E-18.57
P/B2.45
P/S
P/FCF-28.72
EPS-0.3000
Div yield
ROE-13.18%
ROA-12.59%
Debt/Eq0.00
Current23.71
EV/EBITDA-9.92
Gross margin
Net margin
Rev growth-100.00%
EPS growth-16.23%
Price target10.14
Target upside464.90%
Analyst ratingBuy
Institutional85.74%
Ent. value179.03M
Revenue0
Net income-9.6M
Gross profit
Free cash flow-10.85M
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
ExchangeNasdaq
Shares out173.58M
Employees14
ListedWed, Apr 28, 2021
Free float164.96M
Float %99.4%
Short interest30.81M
Days to cover10.8d
Short volume50.7%
Squeeze score84 / 100
Next earnings
EPS forecast
Last EPS vs est−$0.05 vs −$0.04
Last surprise-25.0% miss
Setup gradeC
Conviction47 / 100
Pattern quality
Tech rank26.8 / 100
Group rank50 / 100
Status laneNo active setup
Setup direction
Pattern family
Resistance2.19
Support1.65
Days since event
Candle confirm
News sentiment

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in PALI

All disclosures →
No recent disclosed trades by Congress in PALI. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in PALI · 1 buy

InsiderSideShares
Baltera Robert Jr.
Director · Common Stock · 2026-06-10
Grant336.9K

SEC filings

EDGAR filings in PALI · 1 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.